What is the mechanism driving the reduction of cardiovascular events from glucagon-like peptide-1 receptor agonists? a mini review
- Jared Berndt
- , Soo Liang Ooi
- , Sok Cheon Pak
- Charles Sturt University
- Eli Lilly Australia Pty Ltd.
Research output: Contribution to journal › Review article › peer-review
23
Link opens in a new tab
Citations
(Scopus)
91
Downloads
(Pure)